PTX
Click for more information
0.00% 4.3¢ prescient therapeutics limited

CellPryme-M question

  1. reon1
    1,456 Posts.
    lightbulb Created with Sketch. 492
    clock Created with Sketch.
    11/06/22
    13:52
    Post #: 61956808
    Would the incorporation of CellPryme-M into the manufacturing of an already approved (or clinically advanced) cell therapy product send that product back to phase 1 clinical trials?

    If so, CellPryme-M may only be attractive to pre-clinical or phase 1 assets.

    Anyone able to answer this question? If not, I'll email the company.
    PTX Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ABY Adore Beauty appoints former David Jones exec as new CEO
right-arrow Created with Sketch.
NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $34.62M
Open High Low Value Volume
4.3¢ 4.4¢ 4.3¢ $252 5.87K

Buyers (Bids)

No. Vol. Price($)
4 329464 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 35000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.